Atibuclimab Biosimilar - Research Grade, Low Endotoxin

Atibuclimab Biosimilar - Research Grade, Low Endotoxin

Catalog Number:
A001437400ICH
Mfr. No.:
ICH5016
Price:
$560
  • Size:
    Quantity:
    Add to Cart:
      • Overview
        • Specificity: Detects human CD14. This non-therapeutic antibody uses the same sequence as the therapeutic antibody Atibuclimab.
          Purification method: This monoclonal antibody was purified using multi-step affinity chromatography methods such as Protein A or G depending on the species and isotype.
          Isotype Control: Bulk Human IgG4 Isotype Control (IB4) [ICH2257]
          Endotoxin: ≤ 1.0 EU/mg as determined by the LAL method

          Please contact us at for specific academic pricing.

          Background

          RUO atibuclimab is a chimeric CD14 antibody investigated for the treatment of patients with severe sepsis. It acts as a pattern recognition receptor for bacterial cell wall components in gram-positive and negative bacteria. CD14 antibody action stimulates a pro-inflammatory cytokine cascade often associated with inflammation in sepsis. Atibuclimab neutralization of this antibody results in the inhibition of TNF-a, IL-6 and IL-10, dampening systemic inflammatory responses. Atibuclimab also delays the release of sTNFR(1) and IL-1ra.

      • Properties
        • Isotype
          IgG4
          Reactivity
          human
          Purification
          >95% by SDS-PAGE
          Formulation
          Sterile, preservative-free, solution in PBS. BSA and Azide free.
          Storage
          This biosimilar is stable when stored at 2-8°C. For longer term storage (> 3 months) it is recommended to store this antibody at -20°C or -70°C.
          Molecular Weight
          5mg/ml

          * Products are for research use only. Not for use in diagnostic or therapeutic procedures.

      • Applications
        • Application
          Functional Assays

    Note: If you don't receive our verification email, do the following:

    Copyright © Amerigo Scientific. All rights reserved.